What is LOPJLB’s current signal on MNPR?

LOPJLB’s latest quantitative signal on Monopar Therapeutics Inc. (MNPR) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is MNPR in?

Monopar Therapeutics Inc. (MNPR) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Monopar Therapeutics Inc. based / listed?

Monopar Therapeutics Inc. is based in US, listed on NASDAQ.

Monopar Therapeutics Inc. (MNPR)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$83.98+0.24%Close

SELLCRISIS · day 17

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $563M
Beta: 1.51
P/E (TTM): -34.00

Short % float: 26.09%
Days to cover: 6.0
SI change: +28.7%

1W: +7.71%
1M: -25.27%

vs SPY 1W: +6.15%
vs SPY 1M: -27.04%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary…

Employees: 22
Headquarters: US
Founded: 2019
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 6.7M
Float: 62.1%

monopartx.com ↗

Key executives

Chandler D. Robinson — Co-Founder, Chief Executive Officer, President & Director

Andrew J. Cittadine — Chief Operating Officer

Quan Anh Vu — CFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer

SEC filings

EDGAR · CIK 16454690 · MNPR

Analyst consensus

Buy

Bullish1178.6%

Neutral321.4%

Bearish00.0%

L $105.00Avg $126.00H $145.00

Target$126.00+50.04%

Last$83.98

Key stats

Industry peers

Prediction markets

Company news